Abbott Laboratories · Cash & Short-Term Investments

Latest reported$8.94Bperiod endingDec 31, 2025

ABT FY Cash & Short-Term Investments ($437.50M → $8.94B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

ABT cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	8,939,000,000
Dec 31, 2024	7,967,000,000
Dec 31, 2023	7,279,000,000
Dec 31, 2022	10,170,000,000
Dec 31, 2021	10,249,000,000
Dec 31, 2020	7,148,000,000
Dec 31, 2019	4,140,000,000
Dec 31, 2018	4,086,000,000
Dec 31, 2017	9,610,000,000
Dec 31, 2016	18,775,000,000
Dec 31, 2015	6,125,000,000
Dec 31, 2014	4,460,000,000
Dec 31, 2013	8,098,000,000
Dec 31, 2012	15,174,000,000
Dec 31, 2011	8,097,359,000
Dec 31, 2010	7,323,940,000
Dec 31, 2009	9,932,048,000
Dec 31, 2008	5,079,625,000
Dec 31, 2007	2,820,827,000
Dec 31, 2006	1,373,435,000
Dec 31, 2005	2,956,093,000
Dec 31, 2004	2,058,962,000
Dec 31, 2003	1,286,421,000
Dec 31, 2002	966,127,000
Dec 31, 2001	713,540,000
Dec 31, 2000	1,156,718,000
Dec 31, 1999	723,296,000
Dec 31, 1998	383,317,000
Dec 31, 1997	259,010,000
Dec 31, 1996	123,084,000
Dec 31, 1995	315,697,000
Dec 31, 1994	315,328,000
Dec 31, 1993	378,825,000
Dec 31, 1992	116,600,000
Dec 31, 1991	60,400,000
Dec 31, 1990	34,000,000
Dec 31, 1989	13,600,000
Dec 31, 1988	582,600,000
Dec 31, 1987	519,900,000
Dec 31, 1986	481,600,000
Dec 31, 1985	437,500,000